MYGN

5.4601.44%
MS

Mark S. Verratti

Chief Operating Officer

Mr. Mark S. Verratti was Chief Commercial Officer of Myriad Genetics, Inc. from April 14, 2022 to April 30, 2025 and also serves as its Chief Operating Officer since April 30, 2025. He joined the Myriad Genetics, Inc. on August 30, 2017. He was President of Mental Health, Myriad Neuroscience & Autoimmune of Myriad Genetics, Inc. from 2022 to April 2022. He was President of Myriad Neuroscience & Autoimmune of Myriad Genetics, Inc. from May 01, 2020 to 2022. He was President of Myriad Neuroscience of Myriad Genetics, Inc. from August 01, 2017 to May 01, 2020. He was President of Assurex Health Inc of Myriad Genetics, Inc. until 2018. He is Chief Sales & Business Development Officer and Senior Vice President of Assurex Health, Inc. He joined the Assurex Health, Inc. on March 15, 2016. He was Vice President of International Sales and General Manager of LivaNova USA, Inc. until January 2016. He was employed at LivaNova USA, Inc. from November 2011 to January 2016. He has B.S. in Life Sciences & Physiology from The Pennsylvania State University.

Positions